Manchester BRC receives £4.4M investment to fight the growing threat of antibiotic resistance
Manchester is one of ten leading research centres across the country to receive funding to explore innovative new ways to inform prescribing and identify patterns of resistance. The investment will result in expansion of the NIHR Manchester Biomedical Research Centre’s (BRC’S) respiratory research. The respiratory infections programme of the BRC research is working towards earlier diagnosis and more targeted approach, which match an individual to the treatment most likely to provide the desired response.Smart innovation
Emerging Antimicrobials and Diagnostics in AMR 2019
International Matchmaking Symposium on 19-20 November, 2019 in Amsterdam, The Netherlands.